52A18B60DD9E5C9B8725823B0005814E Hearing Summary CLICS/CLICS2018A/commsumm.nsf PUBLICBILL SUMMARY For HB18-1148HOUSE COMMITTEE ON PUBLIC HEALTH CARE & HUMAN SERVICESDate Feb 20, 2018 Location HCR 0107 HB18-1148 - Amended, referred to the Committee of the Whole 06:00:59 PM Representative Michaelson Jenet, bill sponsor, presented House Bill 18-1148 to the committee. The bill prohibits health insurers from requiring that a person undergo step therapy prior to receiving a federally approved drug for stage four metastatic cancer if the use of the drug is consistent with best practices for treatment of the cancer. Under current law, health insurers are only prohibited from requiring step therapy in instances where a prescription drug mandated under a step therapy protocol has previously been tried by the covered person but was discontinued due to lack of efficacy or adverse event. 06:02:13 PM Representative Michaelson Jenet responded to committee questions regarding the bill. 06:07:28 PM Amendment L.001 was distributed to the committee (Attachment D). 06:11:34 PM Representative Singer proceeded with witness testimony on the bill. 06:12:35 PM Jeanette Hensely, Colorado Senior Lobby, testified in support of the bill. 06:13:45 PM Diane Robinson, Colorado Senior Lobby, testified in support of the bill. Ms. Robinson responded to committee questions. 06:20:06 PM Motion Adopt amendment L.001 (Attachment D). Moved Michaelson Jenet Seconded Pettersen Beckman Catlin Everett Ginal Hooton Landgraf McKean Michaelson Jenet Pabon Pettersen Ransom Danielson Singer YES: 0 NO: 0 EXC: 0 ABS: 0 FINAL ACTION: Pass Without Objection 06:21:26 PM Motion Refer House Bill 18-1148, as amended, to the Committee of the Whole. Moved Michaelson Jenet Seconded Pettersen Beckman Yes Catlin Yes Everett Excused Ginal Yes Hooton Yes Landgraf Yes McKean Yes Michaelson Jenet Yes Pabon Yes Pettersen Yes Ransom Yes Danielson Yes Singer Yes Final YES: 12 NO: 0 EXC: 1 ABS: 0 FINAL ACTION: PASS